Status:
UNKNOWN
Expressive Disclosure and Colorectal Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a Two-part Pilot Study: Part 1 is descriptive and Part 2 is a pilot randomized trial. Part 1 will be a formative study in which individual interviews are conducted with 20 patients previously...
Detailed Description
Colon and rectal cancer patients will be asked to participate in this study. Part 1: Participation in this study will include three tasks: First, you will participate in individual interviews durin...
Eligibility Criteria
Inclusion
- Part 1 - Descriptive Study:
- having a diagnosis of stage I, II, or III colon or rectal cancer;
- having completed treatment for colon or rectal cancer within the past year;
- having the ability to read, speak and write English;
- being a resident of the State of Texas; and
- being 18 years old or older.
- Part 2 - Pilot Randomized Trial:
- having a diagnosis of stage I, II, or III colon or rectal cancer;
- having completed treatment for colon or rectal cancer;
- being a distressed patient: a T score \>63 on the Global Severity Index (GSI) of the Brief Symptom Inventory (BSI) or a T score \>63 on any two primary dimensions of this measure;
- having the ability to read, speak and write English;
- residing within one hour of M.D. Anderson Cancer Center; and
- being 18 years old or older.
Exclusion
- Part 1 - Descriptive Study:
- 1\. Not being able to provide informed consent.
- Part 2 - Pilot Randomized Trial:
- 1\. Not being able to provide informed consent.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT00853203
Start Date
January 1 2009
End Date
August 1 2021
Last Update
December 21 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kelsey-Seybold Clinics
Houston, Texas, United States, 77030
2
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030